Linked Life Data

18318662

Source:http://linkedlifedata.com/resource/pubmed/id/18318662

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-10-10
pubmed:abstractText
Genetic variation in the genes ALOX5AP (arachidonate 5-lipoxygenase-activating protein) and LTA4H (leukotriene A4 hydrolase) has previously been shown to contribute to the risk of MI (myocardial infarction) and stroke in Icelandic and Scottish populations. Both genes encode proteins playing a role in the synthesis of the pro-inflammatory leukotriene B mediators, possibly providing a link between MI and inflammation. The aim of the present study was to investigate whether these associations could be confirmed in a large study of German MI patients. Two previously described four SNP (single nucleotide polymorphism) haplotypes of the ALOX5AP gene (termed haplotype A and B) and one SNP (rs2660899) of the LTA4H gene conferring the greatest risk of MI in previous studies were genotyped in 1211 unrelated MI cases from the German MI Family Study and in 1015 healthy married-in spouses serving as controls. Haplotype B in the ALOX5AP gene was associated with an increased risk of MI in the German population, confirming previously reported associations of this haplotype with CAD (coronary artery disease) in populations from Scotland and Italy. No association with the risk of MI was detected for haplotype A of the ALOX5AP gene or for SNP rs2660899 representing the LTA4H gene. In conclusion, haplotype B of the ALOX5AP gene is associated with an increased risk of MI in a large German study. The present study is the third independent report from a European population describing an increased risk of CAD for carriers of haplotype B of the ALOX5AP gene, which substantiates further a role of this gene in the pathogenesis of CAD in Europeans.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1470-8736
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-15
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18318662-5-Lipoxygenase-Activating Proteins, pubmed-meshheading:18318662-Aged, pubmed-meshheading:18318662-Blood Pressure, pubmed-meshheading:18318662-Carrier Proteins, pubmed-meshheading:18318662-Epoxide Hydrolases, pubmed-meshheading:18318662-Female, pubmed-meshheading:18318662-Gene Frequency, pubmed-meshheading:18318662-Genetic Predisposition to Disease, pubmed-meshheading:18318662-Genetic Variation, pubmed-meshheading:18318662-Genotype, pubmed-meshheading:18318662-Germany, pubmed-meshheading:18318662-Haplotypes, pubmed-meshheading:18318662-Humans, pubmed-meshheading:18318662-Male, pubmed-meshheading:18318662-Membrane Proteins, pubmed-meshheading:18318662-Middle Aged, pubmed-meshheading:18318662-Myocardial Infarction, pubmed-meshheading:18318662-Polymorphism, Single Nucleotide, pubmed-meshheading:18318662-Risk Factors
pubmed:year
2008
pubmed:articleTitle
Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
pubmed:affiliation
Medizinische Klinik II, Universität zu Lübeck, Lübeck, Germany. Patrick.Linsel-Nitschke@uk-sh.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study